Details of the Drug

General Information of Drug (ID: DMINC05)

• Drug Name: FT596

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D08GOI

References

• [1] ClinicalTrials.gov (NCT04245722) FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies. U.S. National Institutes of Health.